Abstract 4887: Comprehensive molecular analysis of pediatric thalamic tumors The effect and evolution of patient selection on outcomes in endoscopic third ventriculostomy for hydrocephalus: A large-scale review of the literature EXTH-58. EFFECTS OF TORC1/2 INHIBITOR MLN0128 ALONE AND IN COMBINATION WITH MEK INHIBITION IN BRAF MUTATED GLIOMA MODELS IN VITRO AND IN VIVO Rb family proteins enforce the homeostasis of quiescent hematopoietic stem cells by repressing Socs3 expression PDTM-40. PEDIATRIC LOW-GRADE GLIOMAS WITH CRAF GENE FUSIONS ARE THERAPEUTICALLY DISTINCT FROM BRAF-FUSIONS BASED ON DIMERIZATION MEDIATED BY N-TERMINAL FUSION PARTNER GERM-01. GENETIC AND EPIGENETIC LANDSCAPE OF CENTRAL NERVOUS SYSTEM GERM CELL TUMORS Abstract 3000: Defining the subclonal landscape of high-risk neuroblastoma Aggressive triple negative breast cancers have unique molecular signature on the basis of mitochondrial genetic and functional defects Novel findings with reassessment of exome data: implications for validation testing and interpretation of genomic data Abstract 2607: The cBioPortal for Cancer Genomics: an open source platform for accessing and interpreting complex cancer genomics data in the era of precision medicine Next Previous
The effect and evolution of patient selection on outcomes in endoscopic third ventriculostomy for hydrocephalus: A large-scale review of the literature
EXTH-58. EFFECTS OF TORC1/2 INHIBITOR MLN0128 ALONE AND IN COMBINATION WITH MEK INHIBITION IN BRAF MUTATED GLIOMA MODELS IN VITRO AND IN VIVO
Rb family proteins enforce the homeostasis of quiescent hematopoietic stem cells by repressing Socs3 expression
PDTM-40. PEDIATRIC LOW-GRADE GLIOMAS WITH CRAF GENE FUSIONS ARE THERAPEUTICALLY DISTINCT FROM BRAF-FUSIONS BASED ON DIMERIZATION MEDIATED BY N-TERMINAL FUSION PARTNER
Aggressive triple negative breast cancers have unique molecular signature on the basis of mitochondrial genetic and functional defects
Novel findings with reassessment of exome data: implications for validation testing and interpretation of genomic data
Abstract 2607: The cBioPortal for Cancer Genomics: an open source platform for accessing and interpreting complex cancer genomics data in the era of precision medicine
